体外膜氧合在感染性肺脓肿非择期大型胸科手术中的应用
这项前瞻性数据库研究纳入德国、英国和西班牙5个中心的127例因感染性肺脓肿接受非择期大型肺手术的患者,其中10例使用ECMO。ECMO使用与死亡率无显著关联(OR 0.70,95%CI 0.08-5.91,P=0.74),术前脓毒症、术前漏气、急性肾衰竭和Charlson合并症指数≥3与死亡率显著升高相关。作者认为ECMO可拓宽感染性非恶性肺脓肿的手术治疗可能性。
要点
- 127例感染性肺脓肿非择期肺手术中10例使用ECMO,死亡率17/127。
- ECMO使用与死亡率无显著关联(OR 0.70,95%CI 0.08-5.91,P=0.74)。
- 术前脓毒症、漏气、急性肾衰竭及Charlson指数≥3与死亡率显著升高相关。
核心结论
- ECMO的应用正在拓宽感染性、非恶性肺脓肿成功手术治疗的可能性。
- 特别是功能可手术性边缘的患者受益于ECMO的可获得性和使用准备。
- 死亡率由既存合并症负担、严重脓毒症和脓毒性休克决定。
研究设计与样本
- 前瞻性数据库研究,纳入德国、英国和西班牙5个中心因感染性肺脓肿接受非择期大型肺手术的所有患者,排除恶性肿瘤和其他操作的胸腔内并发症,共127例。
主要发现
- 中位年龄59岁(四分位距18.75),Charlson合并症指数均值2.83(标准差2.57)。
- 手术方式为肺叶切除89例、全肺切除20例、肺段切除18例;ECMO用于10例(全肺切除2例、肺叶切除8例)。
- 死亡17/127例;术中未遇到ECMO相关并发症。
- ECMO使用与死亡率无显著关联(1/10 vs 16/117;OR 0.70,95%CI 0.08-5.91,P=0.74),肺切除范围与死亡率无显著关联。
- 术前脓毒症(OR 17.84,95%CI 2.29-139.28,P<0.01)、术前漏气(OR 13.12,95%CI 4.10-42.07,P<0.001)、急性肾衰竭(OR 7.00,95%CI 2.19-22.43,P<0.01)和Charlson合并症指数≥3(OR 10.83,95%CI 2.36-49.71,P<0.01)与死亡率显著升高相关。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) support for elective cardiothoracic surgery is well established. In contrast, there are not much data regarding the usefulness and outcome of ECMO in non-elective major lung resections for infectious lung abscess. METHODS: All patients undergoing non-elective major lung surgery for infectious lung abscess at 5 centres in Germany, UK and Spain were enrolled in a prospective database. Malignant disorders and intrathoracic complications of other procedures were excluded. RESULTS: There were 127 patients. The median age was 59 years (interquartile range 18.75). The mean Charlson index of comorbidity was 2.83 (standard deviation 2.57). Surgical procedures were lobectomy (89), pneumectomy (20) and segmentectomy (18). ECMO was used for 10 patients (pneumectomy 2, lobectomy 8) and several more received pre-ECMO treatment. Mortality was 17/127. Intraoperatively no ECMO-associated complications were encountered. EMCO [1/10 vs 16/117; odds ratio (OR): 0.70, 95% confidence interval (CI) 0.08-5.91, P = 0.74] and the extent of pulmonary resection were not associated with higher mortality. Preoperative sepsis (OR: 17.84, 95% CI 2.29-139.28, P < 0.01), preoperative air leak (OR: 13.12, 95% CI 4.10-42.07, P < 0.001), acute renal failure (OR: 7.00, 95% CI 2.19-22.43, P < 0.01) and Charlson index of comorbidity ≥3 (OR: 10.83, 95% CI 2.36-49.71, P < 0.01) were associated with significantly higher mortality. CONCLUSIONS: The application of ECMO is widening the possibilities for successful surgical management of infectious, non-malignant lung abscesses. Particularly, patients with marginal functional operability benefit from the availability and readiness to use ECMO. Mortality is determined by the burden of pre-existent comorbidity, severe sepsis and septic shock.
引用
- Schweigert M, Dubecz A, Giraldo Ospina CF, et al. Use of extracorporeal membrane oxygenation in non-elective major thoracic surgery for infectious lung abscess. Eur J Cardiothorac Surg. 2022. PMID: 35213707. doi:10.1093/ejcts/ezac116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。